These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10464257)

  • 41. CXC chemokine suppression of polymorphonuclear leukocytes apoptosis and preservation of function is oxidative stress independent.
    Dunican AL; Leuenroth SJ; Ayala A; Simms HH
    Shock; 2000 Mar; 13(3):244-50. PubMed ID: 10718383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Critical role of CD4 T cells in PF4/heparin antibody production in mice.
    Zheng Y; Yu M; Padmanabhan A; Aster RH; Yuan L; Wen R; Wang D
    Blood; 2015 Mar; 125(11):1826-9. PubMed ID: 25595736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet binding of IgG from patients with heparin-induced thrombocytopenia.
    Horne MK; Alkins BR
    J Lab Clin Med; 1996 May; 127(5):435-42. PubMed ID: 8621980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet Factor 4 Interactions with Short Heparin Oligomers: Implications for Folding and Assembly.
    Niu C; Yang Y; Huynh A; Nazy I; Kaltashov IA
    Biophys J; 2020 Oct; 119(7):1371-1379. PubMed ID: 32348723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
    Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
    Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic basis of heparin-induced thrombocytopenia.
    Poncz M
    Semin Thorac Cardiovasc Surg; 2005; 17(1):73-9. PubMed ID: 16104364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
    Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
    Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A model of the platelet factor 4 complex with heparin.
    Stuckey JA; St Charles R; Edwards BF
    Proteins; 1992 Oct; 14(2):277-87. PubMed ID: 1409574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of PF4/heparin immunogenicity.
    Suvarna S; Espinasse B; Qi R; Lubica R; Poncz M; Cines DB; Wiesner MR; Arepally GM
    Blood; 2007 Dec; 110(13):4253-60. PubMed ID: 17848616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation.
    Rucinski B; Niewiarowski S; Strzyzewski M; Holt JC; Mayo KH
    Thromb Haemost; 1990 Jun; 63(3):493-8. PubMed ID: 2402751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a whole-cell ELISA to detect additional antibodies in setting of suspected heparin-induced thrombocytopenia.
    Bashover EM; Stefaniuk CM; Harding CV; Maitta RW
    Eur J Haematol; 2019 Aug; 103(2):99-106. PubMed ID: 31107976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Micropatterned array to assess the interaction of single platelets with platelet factor 4-heparin-IgG complexes.
    Medvedev N; Palankar R; Krauel K; Greinacher A; Delcea M
    Thromb Haemost; 2014 May; 111(5):862-72. PubMed ID: 24452831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation.
    Robinson S; Tani M; Strieter RM; Ransohoff RM; Miller RH
    J Neurosci; 1998 Dec; 18(24):10457-63. PubMed ID: 9852583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
    Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes.
    Prechel M; Hudec S; Lowden E; Escalante V; Emanuele N; Emanuele M; Walenga JM
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):294S-300S. PubMed ID: 30419766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemokines in the gastric mucosa in Helicobacter pylori infection.
    Yamaoka Y; Kita M; Kodama T; Sawai N; Tanahashi T; Kashima K; Imanishi J
    Gut; 1998 May; 42(5):609-17. PubMed ID: 9659152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists.
    McColl SR; Clark-Lewis I
    J Immunol; 1999 Sep; 163(5):2829-35. PubMed ID: 10453028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21).
    Khandelwal S; Lee GM; Hester CG; Poncz M; McKenzie SE; Sachais BS; Rauova L; Kelsoe G; Cines DB; Frank M; Arepally GM
    Blood; 2016 Oct; 128(14):1789-1799. PubMed ID: 27412887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.